Presented by
Management Forum

The Pharma Mini MBA

A three-day accelerated management programme to give you the high-performance management skills of an MBA, designed specifically for pharmaceutical/biotechnology professionals and also applicable to medical device/animal health industries

10-12 Nov 2021 + 3 more dates

Enrol now

  • Format: Live online, Classroom
  • CPD: 18 hours for your records
  • Certificate of completion

Course overview

Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.

The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the pharmaceutical case studies from business schools.

Pharmaceutical industry context – business school pharmaceutical case studies on each module

This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.

The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.

The skills you will improve include:

  • Problem-solving
  • Seeing the bigger picture
  • Decision-making,priorities
  • Strategic leadership
  • Implementing strategy
  • Environmental awareness
  • Cross-cultural communication
  • Portfolio management
  • Strategic thinking
  • Leadership
  • Commercial awareness
  • Change management
  • Team-working
  • Project management
  • Increased confidence prioritisation

Key benefits of attending

MBA learning style of the programme

The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.

  • Develop your understanding of the key techniques of an MBA to apply to your work
  • Gain a greater understanding of the pharma industry, its drivers, challenges and opportunities
  • Hear about the latest strategic technology innovations being used and developed in the pharma industry
  • Understand what strategic thinking is and how to use strategy tools
  • Develop your leadership and strategic skills
  • Become more effective in coping with and managing change in the pharma industry
  • Explore the benefits and costs of doing an MBA
  • Take away a Mini MBA toolkit to apply to your job
  • Discuss and learn from real pharma industry case studies

 Pre-course work (sent out to delegates prior to the course)

  • Diagnostic questionnaire – your strategic competencies
  • Discussions of diagnostic output/other areas of value


Who should attend?

A ‘must-attend’ for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.

Enrol now

The The Pharma Mini MBA course will cover:

Strategy and strategic challenges in the pharma industry

  • Strategy and strategic thinking and their importance in the pharma industry
  • Strategic analysis, planning and implementation
    • Environmental analysis
    • Understanding the competitive environment 
    • Strategic options
  • Applying the MBA toolkit
  • Stakeholders and their expectations in the pharma industry
  • Obtaining the value out of strategy in the pharma industry

Commercial management and leadership in the pharma industry

  • New product development and the target product profile
  • Portfolio management used in the pharma industry
  • Understanding business performance
  • The business plan
  • Diagnosing specific performance problems
  • Developing strategic alliances and collaborations in the pharma industry
  • Benefits, costs of doing an MBA and the different routes
  • The role of leadership
    • What are the core competencies of effective leaders in pharma? 
    • Leadership vs management
    • Leadership style and approaches in the pharma industry

Managing innovation in the pharma industry

  • Innovation approaches currently being adopted along the pharma value chain
  • Future innovations in pharma and the life science industries

Hot topics in market access strategy

Leading and implementing pharma strategy and change

  • Leading successful change
    • Diagnosis around change
    • How to create the conditions for successful change
    • Why people resist change and how to manage this
    • Change management including leading a structural reorganisation
    • Creating a team, department and organisation relevant to today’s pharma business needs
    • Team formation and development
  • Implementing strategy and change, essentials of planning and managing projects
    • Project management tools and techniques to use in implementing pharma projects
    • Applying key project management techniques to pharma projects
    • Understanding of cultural awareness to work more effectively with pharma colleagues

Practical application/review

  • Personal development action plan to apply the learning within your own organisation
  • Revisiting your competency assessment – what has shifted?
  • Recommended further reading
  • Practical application of tools (toolkit)

Enrol now

10-12 Nov 2021
23-25 Feb 2022
18-20 May 2022
9-11 Nov 2022

Laura Brown

Dr Laura Brown MBA, BSc (Biochemistry), BSc (Psychology), PhD, Diploma in Clinical Science, FICR, is Chair of an international pharmaceutical management consultancy and course director and senior lecturer for the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. She has also worked as an associate with Cranfield School of Management on the leadership module of the MBA programme and their strategic thinking courses.

Dr Brown worked for Cambridge Corporate Development, an international strategy consultancy, for seven years and has extensive experience in senior management roles in the pharmaceutical industry. She has worked for Wellcome, Hoechst Marion Roussel and Phoenix International and consulted internationally with numerous pharmaceutical companies in the EU, US, Singapore, China and India. She is co-author of several management books including Be Your Own Strategy Consultant, The Ultimate Book of Business Skills and Project Management for the Pharmaceutical Industry.

More details

10-12 Nov 2021

Leela Barham

BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis. This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team. She has more than 10 years experience in the pharmaceutical industry – both at home and abroad – and has worked for all stakeholders in the health care system ranging from patient organisations, the National Health Service, health insurers, and the pharmaceutical industry.

She has particular expertise in public and patient involvement, Patient Access Schemes/risk sharing schemes, the Cancer Drugs Fund, policy on Health Technology Assessment (HTA), and the Pharmaceutical Price Regulation Scheme (PPRS). She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement. She has also had her research published in peer review journals including The Patient and Pharmacoeconomics.

More details

Book The Pharma Mini MBA Live online/Classroom training

10-12 Nov 2021

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 11137

  • GBP 1,499
  • EUR 2,159
  • USD 2,446

Limited places remaining

In your basket 

23-25 Feb 2022

Classroom
London venue TBC

00:00-00:00 UK (London)
Course code 11933

  • GBP 1,499 1,799
  • EUR 2,099 2,519
  • USD 2,338 2,806

Until 19 Jan

  • 3 days classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

In your basket 

18-20 May 2022

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 11622

  • GBP 1,199 1,499
  • EUR 1,739 2,159
  • USD 1,978 2,446

Until 13 Apr

In your basket 

9-11 Nov 2022

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 11757

  • GBP 1,199 1,499
  • EUR 1,739 2,159
  • USD 1,978 2,446

Until 05 Oct

In your basket 

Reviews of IPI's The Pharma Mini MBA training course


Great course, enjoyed it a lot, would recommend.

May 12 2021

Andrei Ilie
Doctor, NHS

May 12 2021

The course greatly matched my expectations and it was an invaluable experience, enriching my understanding and providing me with a toolkit to work on in my career.

Vasileios Eftychidis
Knowledge Transfer Associate - NeuroOncology, Cardiff University

May 12 2021

Very good I enjoyed it, right amount of time and info delivered. Very good interaction with the speakers and all the participants who were from very various backgrounds.

Eric Helmer
Director Clinical Pharmacology, Galapagos

May 12 2021

I've really enjoyed this webinar, covering all I was looking for in a short amount of time while keeping it very interesting and interactive along the way. Laura was very impressive, going through a lot of material and always keeping it very interesting. Case studies were very interesting. I also appreciated the use of different interactive tools for exercises.

Audrey Dicaire-Lavigne
Pharmacovigilance Leader, Jubilant Draximage Inc.

Nov 11 2020

Great course. Intense but good opportunity to learn and well presented. I enjoyed he group work and chatting to everyone too.

Feargal Cosgrove
Licensing Manager – Research & Impact, University of Ulster

Nov 11 2020

Very good, good set of strategic analysis tools was given..

Andreas Gallei
Head of Swine Virology, BIVRC GmbH & Co KG

Nov 11 2020

The guest speakers were a good addition. Overall, well done.

Katie Sippel
Director, Quality Compliance, Novocol Pharmaceutical of Canada Inc.

Nov 4 2019

Overall it was a very interesting course with much knowledge and very useful techniques for strategic thinking. I really enjoyed the case studies and working in teams to accomplish the exercises. Very well done and very well organised.

Theofanis Mantourlias
Senior Manager Formulation Development, Fresenius Kabi Austria GmbH

May 14 2019

Course very useful to get an overview of what a MBA could be. Laura makes the course very interactive and really interesting with many real life examples. Her knowledge of the global pharma industry is quite impressive.

Camille Rivail
Senior Manager Business Development, Avadel Pharmaceuticals SA

May 14 2019

Thank you for a great learning experience!

Jasper Deuring
Medical Affairs , Pfizer

Nov 5 2018

For a 3 day course, we covered a good spread of techniques and information. Having the talks sparked thoughts and also provided a change of pace. The speakers were excellent and Laura's energy & experience was very much appreciated.

Lorraine Borland
Director, Strategic Projects, Sartorius-Stedim BioOutsource

Nov 5 2018

The course gave a real insight into the MBA. There were so many tools I could take back with me and apply to my working life not only for myself , but for my colleagues. The course was a great mix of theory, case studies, external talks and media. Laura was extremely knowledgeable with great credibility within the industry. The course has made me consider a full MBA and also exploring what other courses have Laura as the trainer.

Emma Lennon
Group Manager, GW Pharmaceuticals

May 14 2018

Great energy. Best training I had in a long time.

Florent Noel
Sr Manager QA, Covis Pharma

May 14 2018

Laura [was] very engaging, varied content, good level, Not one boring moment! Deming [offered a] good practical experience in pharma. Great to have had a chance to practically use the tools Laura recommended.

Emma Dupree
Associate Director, Compliance, AbbVie

Nov 5 2018

Laura Brown is a very interesting speaker

Mehdi Sellami
Scientific Director, Laboratoires Galpharma

Nov 5 2018

I think this was a very useful, practical and interesting course. I was able to adopt a strategic thinking that I will be able to implement in my work.

Aintzane Garcia
Medical Department, Faes Farma SA

Nov 5 2018

Good coverage of wide topic area, extremely useful for someone from a single function to get wider overview

Mark Andrews
Technical Director / QP, Deputy Managing Director, Torbay and South Devon NHS Foundation Trust

Nov 1 2017

Really good overview and opportunity to ask many questions. Great course.

Luisa Teixeira
Account Manager, Owen Mumford Ltd

Nov 1 2017

Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated - Would be interesting to have topic about pharma at geographical level

Janneth Ospina Paladines
Senior Regulatory Affairs Associate, Gilead Sciences International

Nov 1 2017

Very interesting

Emine Akin
Marketing & Sales Junior Assistant, Chiesi Group

Nov 1 2017

Overall good, too little time!

Janni Hermansen
Senior PV Advisor, LEO Pharma

May 22 2017

Course was very condensed either reduce the content or extend the course days

Aziz-ul-Islam Chaudhry
Head of Regulatory Affairs, Martindale Pharma

May 22 2017

I found it really practical, lively with possibility to exchange experiences

Mireille Pierrevelcin
Export Area Manager, Cesra Arzneimittel GmbH & Co

May 22 2017

The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great

Diana Binkert
Acino International AG

Nov 28 2016

Excellent. Thoroughly enjoyed it and left feeling like I had learnt something, which, at the end of the day, is the primary goal. I appreciated the method of teaching and enjoyed meeting other people on the course.

Zain Masters
Business Development & Licensing Director, Masters Speciality Pharma

Nov 28 2016

It was a very nice overview on MBA topics overview on MBA topics with a great speaker and interesting discussions

Ricarda Tiemeyer
Drug Safety Scientist & Deputy LSR, Roche Pharma (Switzerland) AG

Nov 28 2016

It exceeded my expectations. Really enjoyed practical sessions and focused environment.

Andriy Kirmach
Associate Director, International Compliance & Ethics, Allergan

Nov 28 2016

Overall excellent course, very well organized. Suitable content, stimulating presentations and excellent speakers.

Suna Horner
Associate Medical Manager, HRA Pharma UK & Ireland Ltd

May 18 2016

It was very informative and engaging with real potential to help with daily practicalities. The full content and delivery is hitting the mark in my opinion.

Irem Bostanci
Account Manager OEM, Owen Mumford Ltd

May 18 2016

Perfect blend of theory and practicality that allowed the attendees to process and apply the information to real world scenarios. Extremely valuable taster into the world and benefits of an MBA!

Dave Wood
Account Director, PharmiWeb Solutions

May 18 2016

An excellent course. I would recommend to all wanting a flavour of an MBA.

Bindu Patel
Senior Manager , Sanofi Pasteur MSD

May 18 2016

Good

Kevin Polhill
Quality and Regulatory Compliance Specialist, Invicta Compliance

May 18 2016

Excellent trainer, lots of info in a short time but actually by the end I thought it was a suitable duration and speed. Would have been nicer to have a little more on the PM part at the end simply because that fits better with my role.

Julia Caldwell
Clinical Trial Manager, Allergan

May 18 2016

This was a well-organised course and both the content and speakers were very good. I do think that the topics could have been tied together better in some instances in the same way as the strategy tools we covered. Some elements such as project management were covered far too quickly to be of any use.

Emma Woods
Pharmaceutical Development Innovation Lead, AstraZeneca Pharmaceuticals Development

May 18 2016

Good mix of people and perspectives; venue was easy to get to. Guest speakers were a good idea.

Julie-Anne Webb
Inside Sales Associate - EU, Core Informatics

May 18 2016

It was rushed in places with things being skipped over - its good to try and include a lot but not if its skipped...doesn't help

GEOF WOLFENDEN
IP & Contracts Manager, AstraZeneca

Nov 28 2016

Provided exactly what I required

Peter Gaines
Chief Medical Officer, Veryan Medical Limited

May 18 2016

Few topics to develop

Edmondo Corona
Plan Engineering Director, AbbVie

UK

  • 4D Pharma PLC
  • AbbVie
  • Aesica Queenborough Limited
  • Alacrita Consulting Ltd
  • Alander Consulting Limited
  • Allergan
  • Allergan UK Limited
  • Amersham Hospital
  • Amicus Therapeutics UK Limited
  • Antisoma Research Ltd
  • Arecor Limited
  • ARROW THERAPEUTICS LTD
  • AstraZeneca
  • AstraZeneca Pharmaceuticals Development
  • AstraZeneca Plc
  • AstraZeneca R&D Charnwood
  • BAUSCH & LOMB INC
  • Bayer Healthcare
  • Biogen IDEC Ltd
  • Biogen Idec Ltd., UK
  • Biogen Ltd
  • BioMarin International
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Pharmaceuticals Ltd
  • Britannia Pharmaceuticals Ltd.
  • BTG International Ltd
  • Cardiff University
  • Celgene Europe Ltd
  • Chiesi Ltd
  • Christina carnegie Consultancy
  • Chugai Pharma Europe Ltd
  • ConvaTec UK Ltd
  • Dechra Veterinary Products
  • Eisai Limited
  • Eisai Ltd
  • Eisai Manufacturing Limited
  • Eli Lilly & Co Ltd
  • Fujifilm Kyowa Kirin Biologics
  • G-Pharm Ltd
  • Galapagos
  • Galen Ltd
  • Genzyme Therapeutics Ltd
  • Gilead Sciences International
  • Gilead Sciences International Limited
  • GlaxoSmithKline
  • GW Pharmaceuticals
  • GW PHARMACEUTICALS PLC
  • Hospira UK Limited
  • HRA Pharma UK & Ireland Ltd
  • Indivior PharmaceuticalUK Ltd
  • Indivior UK Limited
  • Intercept Pharma Europe Ltd
  • Invicta Compliance
  • Janssen
  • Janssen Cilag Ltd
  • Johnson & Johnson
  • Johnson & Johnson Consumer Services EAME Ltd
  • Johnson & Johnson Limited
  • KINGSTON UNIVERSITY
  • LifeScientific
  • Martindale Pharma
  • Masters Speciality Pharma
  • Medimmune UK Limited
  • Medipro Consulting Ltd
  • MEDIS LIMITED
  • Merck Sharp & Dohme Ltd
  • Mitsubishi Tanabe Pharma Europe Ltd
  • MSD Animal Health
  • Mylan
  • NDA Regulatory Science Ltd
  • NHS
  • NOVARTIS VACCINES
  • Owen Mumford Ltd
  • Parexel International
  • Pathway Intermediates
  • Pfizer
  • Pfizer Limited
  • PharmArchitecture Limited
  • PharmiWeb Solutions
  • PRA International Ltd
  • Prostrakan Group Ltd
  • PROTHERICS PLC
  • Quotient Clinical Ltd
  • R + D DIRECTORATE NHS GRAMPIAN
  • Reckitt Benckiser Health Care (UK) Ltd
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Reckitt Benckiser International Limited
  • Red Line Pharmacovigilance
  • Red Line Pharmacovigilance Ltd
  • Regulink Ltd
  • ROCHE
  • Sales-Link, Inc.
  • Sanofi Pasteur MSD
  • Sanofi-Aventis
  • Sartorius-Stedim BioOutsource
  • SCHWARZ PHARMA Limited
  • Scottish National Blood Transfusion Service
  • Shire Pharmaceutical Ltd
  • SI Associates Ltd
  • Stiefel Labs (Maidenhead) Ltd
  • Strategic Consultants
  • Strathclyde Institute of Pharmacy and Biomedical Sciences
  • Takeda Development Centre Europe Ltd
  • TEVA UK
  • Thomson Reuters
  • Thornton & Ross Ltd
  • Toray Industries Inc
  • Torbay and South Devon NHS Foundation Trust
  • Torbay Pharmaceuticals
  • UCB Pharma Limited
  • UCB Pharma Ltd
  • United Therapeutics Europe Ltd
  • UNIVERSITY OF CARDIFF
  • University of Strathclyde
  • University of Ulster
  • Vantia Limited
  • Vectura Group plc
  • Vertex Pharmaceuticals (Europe) Limited
  • Veryan Medical Limited
  • Vifor Pharma UK Ltd
  • Waymade Healthcare plc
  • Winthrop Pharmaceuticals UK Ltd
  • Wyeth Europa Ltd

Switzerland

  • Vifor Pharma AG
  • Acino International AG
  • Amgen (Europe) GmbH
  • Ares Trading SA
  • Covis Pharma
  • Covis Pharma BV
  • Crucell Switzerland AG
  • Elanco Animal Health
  • F. Hoffmann-La Roche Ltd
  • FISHER CLINICAL SERVICES GmbH
  • Helsinn Healthcare S.A.
  • IBSA Institut Biochimique SA
  • Lundbeck (Schweiz) AG
  • Merck Serono SA
  • Novartis Vaccines & Diagnostics AG
  • Novo Nordisk
  • Octapharma AG
  • Roche Pharma (Switzerland) AG
  • Santen SA
  • SERONO INTERNATIONAL SA
  • Serono Pharma International
  • SkyePharma AG
  • Takeda Pharmaceuticals International AG
  • Takeda Pharmaceuticals International GmbH
  • Vifor Pharma AG

Germany

  • ABBOTT GmbH & Co KG
  • Bayer AG
  • Bayer Aktiengesellschaft
  • Bayer Animal Health GmbH
  • Bayer Healthcare
  • Bayer Healthcare AG
  • Bayer Pharma AG
  • BIVRC GmbH & Co KG
  • Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG
  • Boehringer Ingelheim Vetmedica GmbH
  • Boehringer Ingelheim VRC GmbH & Co. KG
  • Cesra Arzneimittel GmbH & Co
  • Grunenthal GmbH
  • HEUMANN PHARMA GMBH & CO
  • Life Molecular Imaging GmbH
  • Medac GmbH
  • Merck KGaA
  • Mundipharma Deutschland GmbH & Co KG
  • Nordmark Arzeneimittel GmbH & Co KG
  • Sandoz International GmbH
  • SCIL TECHNOLOGY GmbH
  • Takeda GmbH

Denmark

  • Albumedix Ltd
  • ALK
  • Alk Abello A/S
  • Boehringer-Ingelheim Danmark A/S
  • Coloplast A/S
  • Dako Denmark A/S
  • DANISH CANCER SOCIETY
  • Ferring Pharmaceuticals A/S
  • Genmab AS
  • LEO Pharma
  • LEO Pharma A/S
  • MERCK SHARP & DOHME
  • Merial Norden A/S
  • Neurosearch A/S
  • Novo Nordisk
  • Novo Nordisk A/S
  • Novo Nordisk AS
  • Novo Nordisk Scandinavia
  • NovoNordisk A/S
  • Takeda Pharma A/S
  • Xellia Pharmaceuticals ApS

France

  • Aeras Global TB Vaccine Foundation
  • Astrazeneca
  • Avadel Pharmaceuticals SA
  • Baxter SAS
  • GALDERMA R & D
  • IPSEN INNOVATION
  • Ipsen Pharma SAS
  • Laboratoires Fournier
  • LFB Biomedicaments
  • Sanofi-aventis
  • SANTEN
  • Teva Sante
  • Wyeth Pharmaceuticals

Netherlands

  • Abbott Biologicals BV
  • Abbott Healthcare Products BV
  • Abbott Vascular B.V.
  • Amgen Europe BV
  • Astellas Pharma Europe BV
  • BIOGEN IDEC BV
  • FERRING BV
  • Merck Sharp & Dohme
  • Merus NV
  • Pfizer
  • Sanquin Plasma Products B.V.
  • Sun Pharma
  • Tjoapack Netherlands B.V.

Belgium

  • Aratana Therapeutics NV
  • Chiesi Group
  • Cyberonics Europe BVBA
  • Fujirebio-Europe NV
  • Galapagos NV
  • Glaxo Smithkline Biologicals
  • Janssen Infectious Diseases - Diagnostics BVBA
  • Janssen Pharmaceutica NV
  • Ortho Biotech, Johnson & Johnson
  • UCB Pharma SA
  • VIB
  • ViroVet BVBA

Spain

  • ALMIRALL, S.A.
  • Centro de Investigacion Farmaceutica
  • Chemo Espana SL
  • Faes Farma SA
  • Laboratorios Leti SL Unipersonal
  • PHARMACEUTICAL RESEARCH ASSOCIATES

Austria

  • Baxter Innovations GmbH
  • Eli Lilly Regional Operations GmbH
  • Fresenius Kabi Austria GmbH
  • Octapharma Pharmazeutika Produktionsges.m.b.H.
  • Valneva Austria GmbH

Croatia

  • Agencije Za Lijekove I Medicinske Proizvode
  • Belupo d.d.
  • Europharma doo
  • EWOPHARMA d.o.o.
  • Pliva - Research & Development Ltd

Italy

  • AbbVie
  • Chiron S.r.l
  • GlaxoSmithKline Vaccines & Diagnostics s.r.l.
  • Menarini Ricerche Spa
  • Zambon Company SpA

Canada

  • GSK Biologicals
  • Jubilant Draximage Inc.
  • LAURENENTIAN UNIVERSITY
  • Novocol Pharmaceutical of Canada Inc.

Poland

  • PHYTOPHARM KLEKA SA
  • POLPHARMA GROUP
  • Polpharma SA
  • Radiometer Sp. z o.o.

Sweden

  • Astra Zeneca AB
  • Orexo AB
  • OTSUKA PHARMA SCANDINAVIA AB
  • Wellspect Healthcare

Ireland

  • ENTERPRISE IRELAND
  • Pfizer Limited
  • Shire Pharmaceuticals Ireland Ltd

Kuwait

  • Al Hafez Trading Est
  • Gharghour Arabian Gulf Co. w.I.I.
  • Yiaco Medical Co

Egypt

  • Minapharm Pharmaceuticals
  • Rhein-Minapharm Biogenetics

Finland

  • Orion Corporation Orion Pharma
  • Orion Pharma

Portugal

  • BIAL - Portela & Companhia SA
  • JABA FARMACEUTICA S.A

Saudi Arabia

  • Avalon Pharma
  • Saudi Food and Drug Authority

United Arab Emirates

  • Hospira (ME & NA)
  • Newbridge Pharmaceuticals

United States of America

  • Core Informatics
  • TITAN PHARMACEUTICALS INC

Bulgaria

  • ASSOCIATION OF BULGARIAN

Czech Republic

  • Pro-Med CS Praha AS

Ecuador

  • Grunenthal

Georgia

  • GEOPHARMA LIMITED

Iceland

  • Actavis Group PTC ehf.

India

  • MAK COLLEGE OF PHARMACY AND MAK LABS

Israel

  • Compugen Limited

Jordan

  • Pharma International Co - PIC

Lithuania

  • UAB GLAXOSMITHKLINE LIETUVA

Nigeria

  • Link Health Care Pharmacy Nigeria Limited

Norway

  • Pronova BioPharma

Romania

  • Arriello Group

Russia

  • Association of Clinical Trials Organizations

South Africa

  • AstraZeneca South Africa (Pty) Ltd

Tunisia

  • Laboratoires Galpharma

Turkey

  • BOEHRINGER INGELHEIM

Yemen

  • Ibn Hayyan & Mohdar Co (Eisai Co Ltd)

Enrol now

Multiple colleagues?
Talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra BEER
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy